Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure.
Thomas R GodecDaniel I BromageMar Pujades-RodriguezAntonio CannatàArturo Gonzalez-IzquierdoSpiros DenaxasHarry HemingwayAjay M ShahDerek M YellonTheresa A McDonaghPublished in: ESC heart failure (2022)
When considering changes in antidiabetic treatment over time, all drug classes were associated with reduced risk of cardiovascular mortality and HF hospitalization.